Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive
Veracyte, Inc. · SERVICES-MEDICAL LABORATORIES · Now $48.18
+11% in 7d after detection
Post-detection moves
1h
—
1d
+8.4%
3d
+8.0%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS